Bobby Harshbarger
Coverage of Bobby Harshbarger in the Nexus archive.
- STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
An FDA advisory panel will discuss allowing compounding pharmacies to manufacture seven peptides currently deemed unsafe. The panel includes members with potential conflicts of interest, such as physicians who prescribe peptides and Tennessee state Sen. Bobby Harshbarger, whose mother, U.S. Rep. Diana Harshbarger, advocates for looser peptide regulations.
- STAT+: Longevity, wellness physicians named to panel advising FDA on peptides
The FDA announced eight new panelists to advise on regulations for compounding pharmacies manufacturing peptides. Most panelists are linked to businesses promoting peptides, and one, Bobby Harshbarger, is a pharmacist and Tennessee state senator. A professor raised concerns about the panelists' ties to unproven peptide and stem cell treatments.
- CVS sues Tennessee over pharmacy benefit manager monopoly law
CVS Health sued Tennessee after the state passed a law banning pharmacy benefit managers (PBMs) from owning pharmacies, targeting CVS as the only company in Tennessee with both a PBM and physical pharmacies. The law aims to address disparities in drug reimbursement rates between affiliated and non-affiliated pharmacies, with state lawmakers calling it PBM reform. CVS claims the law is unconstitutional and will restrict patient access to medications.